Literature DB >> 20674793

Emerging and established parasitic lung infestations.

Vannan Kandi Vijayan1, Tarek Kilani.   

Abstract

Many lung infestations from established and newly emerging parasites have been reported as a result of the emergence of HIV/AIDS, the increasing use of immunosuppressive drugs, increasing organ transplantations, the increase in global travel, and climate change. A renewed interest in parasitic lung infections has been observed recently because many protozoal and helminthic parasites cause clinically significant lung diseases. The diseases caused by these parasites may mimic common and complicated lung diseases ranging from asymptomatic disease to acute respiratory distress syndrome requiring critical care management. The availability of new molecular diagnostic methods and antiparasitic drugs enables early diagnosis and prompt treatment to avoid the morbidity and mortality associated with these infestations. Good hygiene practices, improvement in socioeconomic conditions, vector control measures, and consumption of hygienically prepared and properly cooked food are essential to reduce the occurrence of parasitic infestations. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674793     DOI: 10.1016/j.idc.2010.04.002

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  4 in total

Review 1.  Surgery for parasitic lung infestations: roles in diagnosis and treatment.

Authors:  Bibhusal Thapa; Ranjan Sapkota; Michelle Kim; Stephen Arthur Barnett; Prakash Sayami
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

2.  Phosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite.

Authors:  Thomas Seebeck; Geert Jan Sterk; Hengming Ke
Journal:  Future Med Chem       Date:  2011-08       Impact factor: 3.808

Review 3.  The Relevance of the Bacterial Microbiome, Archaeome and Mycobiome in Pediatric Asthma and Respiratory Disorders.

Authors:  Carolin Baehren; Eleni Buedding; Aliyah Bellm; Frank Schult; Anton Pembaur; Stefan Wirth; Anja Ehrhardt; Friedrich Paulsen; Jan Postberg; Malik Aydin
Journal:  Cells       Date:  2022-04-10       Impact factor: 7.666

4.  Bronchopulmonary lophomoniasis: emerging disease or unsubstantiated legend?

Authors:  Rafael Martínez-Girón; Hugo Cornelis van Woerden
Journal:  Parasit Vectors       Date:  2014-06-23       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.